Page last updated: 2024-11-12
pyragonicin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
pyragonicin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 10393745 |
CHEMBL ID | 448093 |
MeSH ID | M0496640 |
Synonyms (3)
Synonym |
---|
CHEMBL448093 |
pyragonicin |
(2s)-2-methyl-4-[(2r,8r,11r)-2,8,11-trihydroxy-11-[(2r,5r,6r)-5-hydroxy-6-tetradecyloxan-2-yl]undecyl]-2h-furan-5-one |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (7)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID379112 | Cytotoxicity against human MIA PaCa2 cells | 1999 | Journal of natural products, Mar, Volume: 62, Issue:3 | Annonaceous acetogenins: recent progress. |
AID379124 | Cytotoxicity against human HT-29 cells | 1999 | Journal of natural products, Mar, Volume: 62, Issue:3 | Annonaceous acetogenins: recent progress. |
AID379125 | Cytotoxicity against human A-498 cells | 1999 | Journal of natural products, Mar, Volume: 62, Issue:3 | Annonaceous acetogenins: recent progress. |
AID379121 | Toxicity in brine shrimp | 1999 | Journal of natural products, Mar, Volume: 62, Issue:3 | Annonaceous acetogenins: recent progress. |
AID379111 | Cytotoxicity against human PC-3 cells | 1999 | Journal of natural products, Mar, Volume: 62, Issue:3 | Annonaceous acetogenins: recent progress. |
AID379123 | Cytotoxicity against human MCF7 cells | 1999 | Journal of natural products, Mar, Volume: 62, Issue:3 | Annonaceous acetogenins: recent progress. |
AID379122 | Cytotoxicity against human A549 cells | 1999 | Journal of natural products, Mar, Volume: 62, Issue:3 | Annonaceous acetogenins: recent progress. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 13.03
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.03) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (20.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 4 (80.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |